has reported Consolidated financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 53.2948 crores during the period ended June 30, 2022 as compared to Rs. 49.6486 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. 12.8589 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 10.5074 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. 4.01 for the period ended June 30, 2022 as compared to Rs. 3.27 for the period ended March 31, 2022.
Total Income | ₹ 53.2948 crs | ₹49.6486 crs | 7.34% |
Net Profit | ₹12.8589 crs | ₹10.5074 crs | 22.38% |
EPS | ₹4.01 | ₹3.27 | 22.63% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 53.2948 crores during the period ended June 30, 2022 as compared to Rs.44.4480 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.12.8589 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.9.8464 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.4.01 for the period ended June 30, 2022 as compared to Rs.3.07 for the period ended June 30, 2021.
Total Income | ₹ 53.2948 crs | ₹44.4480 crs | 19.90% |
Net Profit | ₹12.8589 crs | ₹9.8464 crs | 30.59% |
EPS | ₹4.01 | ₹3.07 | 30.62% |
Source : Equity Bulls
Keywords
IndoBoraxandChemicals
Q1FY23
ResultUpdate